[VRTX] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
31-Oct-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -78.49%
YoY- -55.32%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 1,524,485 1,515,107 1,413,265 949,828 941,293 858,435 870,106 45.38%
PBT 824,770 657,534 676,950 70,666 327,138 320,165 32,497 765.33%
Tax -12,500 54,781 93,716 13,148 59,711 51,534 -1,492,599 -95.88%
NP 837,270 602,753 583,234 57,518 267,427 268,631 1,550,527 -33.71%
Tax Rate 1.52% -8.33% -13.84% -18.61% -18.25% -16.10% 4,593.04% -
Total Cost 687,215 912,354 830,031 892,310 673,866 589,804 -680,421 -
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin 54.92 39.78 41.27 6.06 28.41 31.29 178.20 -54.40%
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS 3.22 2.32 2.26 0.22 1.04 1.05 6.08 -34.56%
EPS Diluted 3.18 2.29 2.23 0.22 1.03 1.03 5.97 -34.31%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.